Interaction of immunoactive monokines (interleukin 1 and tumor necrosis factor) in the bivalve mollusc Mytilus edulis ( Contributed by Berta Scharrer, March 13, 1990 ABSTRACT Mytilus edulis has been the subject of recent studies to determine whether the relationship between the immune and neuroendocrine systems seen in vertebrates also exists in invertebrates. The effects of mammalian monokines were studied in Mytilus immunocytes previously shown to produce and react to opioid peptides. These invertebrate cells respond to interleukin 1 (IL-1) and tumor necrosis factor (TNF), both in vitro and in vivo, in a manner similar to that of human granulocytes. As in the mammalian monokine network, the effect of IL-1 on the immunocytes is brought about, at least in part, by its stimulatory effect on the formation of TNF. In addition, the presence of immunoreactive IL-1 and TNF in Mytilus hemolymph was demonstrated.
opioid peptides. These substances are present in the ganglionic cells of this invertebrate (1) . Moreover The present study was undertaken to determine whether Mytilus also possess monokines and a monokine-like network. To this end, we chose to study the effects of two interacting monokines, interleukin 1 (IL-1) and tumor necrosis factor type a (TNF-a) (4, 5) . We were able to show that Mytilus immunocytes, like human granulocytes, respond to these two factors. We further demonstrated that, as in the human system (5), the effects of IL-1 are attributable, at least in part, to its induction of TNF-a formation. Finally, we showed that Mytilus hemolymph contains IL-1 and TNF-a immunoreactivity.
MATERIALS AND METHODS
Animals. M. edulis were obtained from the shores of Long Island Sound at Wading River. The animals were used within 3 hr from the time of collection, and hemocytes were prepared as previously noted in detail (6) . Briefly, hemocytes were aspirated by syringe from the area of the posterior adductor muscle in 0.1-ml quantities from "40 animals, pooled, and used as noted below.
Reagents. Recombinant human TNF-a was obtained from Suntory Ltd. (Tokyo). Recombinant human IL-la and antibodies to IL-1 and TNF-a (both polyclonal rabbit preparations against recombinant immunogen) were obtained from Genzyme. ELISA kits for IL-1 and TNF-a were obtained from Cistron Biotechnology (Pine Brook, NJ).
Determination of Immunoreactive IL-1 and TNF-a by ELISA. Hemolymph from 200 Mytilus was removed and concentrated by dialysis against polyethylene glycol (""75-fold), followed by equilibrium dialysis against phosphatebuffered saline. Samples were subjected to ELISA for human TNF-a and IL-18. ELISAs were performed by a four-stage procedure in a microtiter plate coated with monoclonal antibody specific for either IL For adherence assays, 100 .ul of hemolymph-containing cells plus the respective reagent were placed on a glass slide precoated with a 2% bovine serum albumin solution (6) . The mixture was allowed to incubate at room temperature (23°C) for 10 min. The slide was then gently tilted, allowing excess fluid to run off, and examined by light microscopy and Zeiss-Zonax reflectance computer analysis (6) . Changes in conformation of hemocytes were determined by inoculating them into the space provided by an inverted coverslip placed on a slide over a ring of Vaseline. This method allowed observation for up to 1 hr without drying of cells. The mixture was allowed to incubate at room temperature for another 10
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The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact. min before the cell preparations were examined by use of phase contrast and Nomarski optics coupled with a Zeiss Axiophot microscope (7) . Measurements were taken with a Zeiss Videoplan/Vidas image analysis system. Before they were recorded, specific images were converted to binary images after frame grabbing. Simultaneously, specific cells were photographed by an internal Sony video photography system combined with a time-lapse video synchronization system (JVC). Cellular shape ranged from rounded (inactive) to ameboid (active).
Changes in cellular conformation based on measurements of cellular area and perimeter were mathematically expressed by the use of the form-factor calculations of the Zeiss Vidas analysis system whereby the equation { [4 x 
RESULTS
The effects of two monokines, IL-1 and TNF-a, on immunoactive cells of Mytilus, which closely resemble the granulocyte-monocyte-macrophage lineage of vertebrates (8), were determined. Recombinant human IL-1 and TNF-a have a stimulatory effect on these cells (Fig. 1) , as demonstrated by the following experiments. IL-1 can stimulate a specific population of cells to increase their area in a dose-response fashion (Fig. 2) . This effect can be blocked by prior treatment with IL-1 antibody. TNF-a, in a dose-dependent fashion similar to IL-1, increases the relative reflectance of the cells and also causes the cells to flatten, as indicated by the measured increase in their area and their perimeter (Fig. 3 A  and B) . Typically, they display form-factor values of 0.40, indicating an activated state (Fig. 3C) . As a rule, control cells during the observation period remain rounded and generally inactive (Fig. LA) . It is interesting to note that the responses listed are blocked by prior addition to the cells of specific antibodies to IL-1 or TNF-a (Figs. 2 and 3) . Addition of normal rabbit serum as a control antibody had no effect on the responses (data not shown). We also tested the possible influence of recombinant human y interferon on Mytilus cells but found no effect during our period of observation (data not shown). This is not surprising since 'y interferons in general exhibit extreme species specificity in their actions (9) .
It also was of interest to determine the effect of TNF-a on hemocytes when administered in vivo-i.e., when the TNF-a is injected into the animal. After TNF-a injection into Mytilus, the number of circulating hemocytes recovered by aspiration was reduced (Fig. 3D) , in an anti-TNF-a reversible manner, presumably because the activated cells migrate into various tissues (7) .
In vertebrates, some of the effects of IL-l are thought to be attributed to its induction of TNF-a formation (5). We determined whether a similar mechanism might occur in Mytilus. IL-l was placed on the cells in the absence or presence of antibody to TNF-a. As shown in Fig. 2 B and C, anti-TNF-a almost completely blocked the response induced by IL-l. The remainder of the response was abolished by antibody to IL-i. Thus, it appears that IL-i achieves part of its effect through stimulating the formation of a TNF-a-like molecule, while the rest appears to be due to IL-l itself.
Since this experiment tends to indicate that a TNF-a-like molecule is produced by Mytilus cells, we wanted to determine whether this substance or an IL-i-like molecule or both can be detected in the hemolymph. Concentrated hemolymph from 200 animals was subjected to ELISA for IL-i or TNF-a. As shown in Fig. 4 , immunoreactive TNF-a and IL-i are present in the hemolymph. These quantities are roughly equivalent to 7 fM and 15 fM, respectively, when the concentration of the hemolymph is taken into consideration (see Fig. 4 legend) .
DISCUSSION
Mytilus immunocytes share a number of properties with cells of the human granulocyte-monocyte-macrophage lineage (10) . They have the potential to become motile in all of the tissues examined (6) . The (12) . Invertebrate immunocytes produce and respond to opioid neuropeptides (6) .
The present study demonstrates that Mytilus hemocytes also contain and respond to two monokines, IL-1 and TNF-a. More specifically, (i) they respond to recombinant human IL-1 and TNF-a; (ii) these responses can be blocked by antibody specific for either monokine; (iii) the IL-1 response can be partially blocked by antibody to TNF-a, while the remainder of the response is blocked by antibody to IL-1, indicating that IL-1 exerts its effect not only directly but also through a TNF-a-like intermediate; and (iv) immunoreactive IL-1 and TNF-a can be detected by specific ELISA in Mytilus hemolymph.
Previous reports have demonstrated the presence in starfish and tunicates of factors with IL-1-like effects on vertebrate and invertebrate immunocytes (13) (14) (15) (16) . In one of these studies, Beck et al. (16) attempted to determine the presence of TNF-a activity in tunicates, but they were unsuccessful. Other "lymphokine-like" activities have been described in invertebrates (17) . To our knowledge, however, monokine production, action, and cascade effects in invertebrates have not been reported. There is still uncertainty about the degree of homology of these immunoreactive substances in humans and Mytilus. In this respect, it is of interest that the application of human TNF-a at a concentration above 1 fM is lethal in Mytilus, even though its immunoactivity resembles that of its Mytilus counterpart. Perhaps in the long course of evolution, the toxicity of the human TNF-a may have markedly increased. We have yet to isolate and characterize the TNF-a of Mytilus, but our preliminary results tend to indicate that a substance present in Mytilus hemolymph exerts a toxic effect also on susceptible mammalian cells similar to that of human TNF-a.
The results of the present study strongly suggest that monokines are "ancient" signal molecules that have evolved over a period of millions of years. By the same token, the granulocyte-monocyte-macrophage cell family may be considered to be "primitive" in mammalian immune functions (10) . At present, we are unsure of the forces that normally control expression of these substances in invertebrates. It is possible that naturally occurring inducers-i.e., endotoxins-could be sufficient to trigger a response but our findings open the possibility that an even larger network of soluble immune signal molecules may be operating in invertebrates such as Mytilus.
